Managing IBD in patients with previous cancers

Sarah E Minnis-Lyons, Zara Aiken, Shien Chow, Shahida Din

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

A frequent dilemma faced in the inflammatory bowel disease (IBD) clinic is how to best treat a patient with a previous cancer diagnosis. The changing demographics of our patient population will make this quandary more common. Previous guidance has emphasised the importance of lengthy postcancer drug holidays and cautious use of IBD therapies. However, accumulating evidence suggests this approach may be unnecessarily conservative. This review considers recent evidence on the safety of IBD drugs, cancer and recurrent cancer risk in patients with IBD and provides a framework for shared decision making involving patient, gastroenterologist and oncologist.
Original languageEnglish
Pages (from-to)e44-e50
JournalFrontline Gastroenterology
Issue numbere1
Early online date8 Jun 2022
Publication statusE-pub ahead of print - 8 Jun 2022


Dive into the research topics of 'Managing IBD in patients with previous cancers'. Together they form a unique fingerprint.

Cite this